We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

4 hedge funds and large institutions have $124K invested in Cyclo Therapeutics, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $86K → $124K (+$38K)

33% more funds holding

Funds holding: 3 → 4 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$114K

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$259
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$77K +$114K +219,795 New
WVP
2
Worth Venture Partners
New Jersey
$26K -$259 -500 -0.7%
EAM
3
Empery Asset Management
New York
$21K – – –

CYTHW Hedge Fund Activity: Q3 2022 in Review

4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q3 2022, worth a combined $124K — up 44% from $86K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CYTHW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $114K. The largest seller was Worth Venture Partners, cutting an estimated $259.

  • 4 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q3 2022, up from 3 in Q2 2022.
  • Funds reported $124K of Cyclo Therapeutics, Inc. Warrant stock for Q3 2022, up 44% quarter-over-quarter.
  • 1 fund opened new Cyclo Therapeutics, Inc. Warrant positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest Cyclo Therapeutics, Inc. Warrant buyer in Q3 2022 was AIGH Capital Management, an estimated $114K added.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q3 2022 was Worth Venture Partners, an estimated $259 sold.

Based on aggregated 13F filings for Q3 2022.